Post Profile






Study examines safety and effectiveness of infliximab biosimilar in patients with inflammatory bowel

(Wiley) Biosimilars are biologic agents that highly similar to original biomedical medications (oringinators), but are much cheaper.
read more

share

Related Posts


Proactive Monitoring Of Inflammatory Bowel Disease Therapy Could Prolong Effectiveness

Health : Newswise Medical News

Proactive monitoring and dose adjustment of infliximab, a medication commonly used to treat inflammatory bowel disease (IBD), could improve a patient's chances of having a long-term successful response to therapy, a pilot observatio...

Subjective complaints may cause patients to stop treatment after switching to a biosimilar

Health : EurekAlert: Health

(Wiley) A biosimilar is a biological medicine that shows no clinically meaningful differences with another already approved biological medicine (the 'reference medicine').

Biosimilar switching not suitable for all patients

Academics / General Science : ScienceDaily: Science Society

The results of a study showed that when antibodies develop in response to the biological treatment Remicade® (infliximab), they also cross-react with the biosimilar of infliximab (CT-P13: Inflectra® or Remsima®). These findings sugg...

'Biosimilars' for Children with IBD Need More Research, ESPGHAN Expert Panel States

Health : Newswise Medical News

Children with inflammatory bowel disease (IBD) who are doing well on specific biological medications should not be switched to recently approved "biosimilar" products, concludes an expert consensus statement of the European Society ...

Biosimilar of costly inflammatory bowel disease therapy found safe and effective

Health : EurekAlert: Health

(Wiley) Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab (which targets tumour necrosis factor alpha), but at considerable cost.

Comments


Copyright © 2016 Regator, LLC